tiprankstipranks

G1 Therapeutics downgraded to Market Perform from Outperform at Raymond James

Raymond James downgraded G1 Therapeutics to Market Perform from Outperform after the company agreed to be acquired by Pharmacosmos for $7.15 per share in cash.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue